BUSINESS ACQUISITIONS (Tables)

12 Months Ended

Dec. 31, 2025

BUSINESS ACQUISITIONS

Schedule of fair value of consideration for the DDS Rank acquisition

Purchase Price:
		Amount
Cash paid to seller			200,000
Notes payable issued to seller			200,000
Series A preferred stock issued to seller			200,000
Total purchase consideration		$	600,000

Schedule of fair value of assets acquired

Purchase Price Allocation
Developed technology		$	90,000
Customer relationships			360,000
Trademarks and Trade Names			120,000
Non-Compete agreement			30,000
Net assets acquired		$	600,000

Purchase Price Allocation
Accounts receivable		$	217,878
Unbilled receivables			165,855
Fixed assets			5,135
Website domains			90,000
Customer relationships			490,000
Trademarks and trade names			530,000
Non-compete agreement			20,000
Goodwill			1,407,602
Deferred revenues			(526,470	)

Net assets acquired		$	2,400,000

Schedule of fair value of consideration for the eastern standard

Purchase Price:

Cash		$	500,000
Promissory Note, net of discount			1,250,000
Preferred Shares			410,000
Roll-over equity			240,000
Total purchase consideration			2,400,000

Schedule of unaudited pro forma financial information

		Year ended December 31, 2024
Revenue		$	11,456,601
Operating loss			(2,099,022	)
Net loss			(1,446,510	)
Net loss per common share		$	(0.37	)
Weighted Average common shares outstanding			5,117,941